Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov 20;86(1):18-19.
doi: 10.1097/MS9.0000000000001534. eCollection 2024 Jan.

Advancing intraoperative tumour detection and molecular-guided precision surgery, FDA's approval of pafolacianine injection: an editorial

Affiliations
Editorial

Advancing intraoperative tumour detection and molecular-guided precision surgery, FDA's approval of pafolacianine injection: an editorial

Mahnoor Fayaz et al. Ann Med Surg (Lond). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article

References

    1. Kashiwagi S, Choi HS. Ovarian cancer-targeted near-infrared fluorophores for fluorescence-guided surgery. Ann Transl Med 2023;11:274–274. - PMC - PubMed
    1. Mahalingam SM, Kularatne SA, Myers CH, et al. Evaluation of novel tumor-targeted near-infrared probe for fluorescence-guided surgery of cancer. J Med Chem 2018;61:9637–9646. - PubMed
    1. Dindere ME, Tanca A, Rusu M, et al. Intraoperative tumor detection using pafolacianine. Int J Mol Sci 2022;23:12842. - PMC - PubMed
    1. Van Keulen S, Hom M, White H, et al. The evolution of fluorescence-guided surgery. Mol Imaging Biol 2023;25:36–45. - PMC - PubMed
    1. Cision, PR Newswire On Target Laboratories, Inc. On Target Laboratories announces FDA approval of CYTALUXTM (pafolacianine) injection for identification of ovarian cancer during surgery, 2021. https://www.prnewswire.com/news-releases/on-target-laboratories-announce...

Publication types